These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35299961)

  • 1. MiR-200c-3p Regulates DUSP1/MAPK Pathway in the Nonalcoholic Fatty Liver After Laparoscopic Sleeve Gastrectomy.
    Zhang TT; Wang Y; Zhang XW; Yang KY; Miao XQ; Zhao GH
    Front Endocrinol (Lausanne); 2022; 13():792439. PubMed ID: 35299961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleeve gastrectomy ameliorated high-fat diet (HFD)-induced non-alcoholic fatty liver disease and upregulated the nicotinamide adenine dinucleotide +/ Sirtuin-1 pathway in mice.
    Hua R; Wang GZ; Shen QW; Yang YP; Wang M; Wu M; Shao YK; He M; Zang Y; Yao QY; Zhang ZY
    Asian J Surg; 2021 Jan; 44(1):213-220. PubMed ID: 32712045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes.
    Wang XY; Lu LJ; Li YM; Xu CF
    Life Sci; 2022 Nov; 308():120925. PubMed ID: 36057399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of circ PTK2 suppresses the progression of nonalcoholic fatty liver disease via the miR-200c/SIK2/PI3K/Akt axis.
    Li Y; Cen CQ; Liu B; Zhou L; Huang XM; Liu GY
    Kaohsiung J Med Sci; 2022 Sep; 38(9):869-878. PubMed ID: 35791807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPK
    Yu Y; He C; Tan S; Huang M; Guo Y; Li M; Zhang Q
    Anal Cell Pathol (Amst); 2021; 2021():4853355. PubMed ID: 35004133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of Setdb2 promotes alternative activation of macrophages via the PI3K/Akt pathway to attenuate NAFLD after sleeve gastrectomy.
    Yu T; Wang L; Cheng Y; Zhang Y; Zhu J; Zhang G; Hu S
    Biochem Biophys Res Commun; 2024 Sep; 726():150264. PubMed ID: 38905784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-103-3p promotes hepatic steatosis to aggravate nonalcoholic fatty liver disease by targeting of ACOX1.
    Ding J; Xia C; Cen P; Li S; Yu L; Zhu J; Jin J
    Mol Biol Rep; 2022 Aug; 49(8):7297-7305. PubMed ID: 35606603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in bile acids after sleeve gastrectomy improves metabolism by activating GPBAR1 to increase cAMP in mice with nonalcoholic fatty liver disease.
    Li G; Xu X; Chai L; Guo Q; Wu W
    Immun Inflamm Dis; 2024 Jul; 12(7):e1149. PubMed ID: 39031498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-337-3p confers protective effect on facet joint osteoarthritis by targeting SKP2 to inhibit DUSP1 ubiquitination and inactivate MAPK pathway.
    Jian S; Luo D; Wang Y; Xu W; Zhang H; Zhang L; Zhou X
    Cell Biol Toxicol; 2023 Jun; 39(3):1099-1118. PubMed ID: 34697729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced miR-200b and miR-200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1.
    Guo J; Fang W; Sun L; Lu Y; Dou L; Huang X; Sun M; Pang C; Qu J; Liu G; Li J
    Oncotarget; 2016 Jun; 7(24):36207-36219. PubMed ID: 27166182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis.
    Cui J; Wang Y; Xue H
    Bioengineered; 2022 Apr; 13(4):8370-8381. PubMed ID: 35322757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Indole-3-Acetic Acid in NAFLD Amelioration After Sleeve Gastrectomy.
    Wang Y; Wang G; Bai J; Zhao N; Wang Q; Zhou R; Li G; Hu C; Li X; Tao K; Xia Z; Wang G
    Obes Surg; 2021 Jul; 31(7):3040-3052. PubMed ID: 33973136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
    Zhang T; Zhao X; Steer CJ; Yan G; Song G
    Metabolism; 2018 Aug; 85():183-191. PubMed ID: 29625129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of JHDM1D-AS1 alleviates neuroinflammation and neuronal injury via targeting miR-101-3p-DUSP1 in spinal cord after brachial plexus injury.
    Liu LP; Zhang J; Pu B; Li WQ; Wang YS
    Int Immunopharmacol; 2020 Dec; 89(Pt A):106962. PubMed ID: 33039970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?
    Esquivel CM; Garcia M; Armando L; Ortiz G; Lascano FM; Foscarini JM
    Obes Surg; 2018 Dec; 28(12):4022-4033. PubMed ID: 30121855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-665-3p exacerbates nonalcoholic fatty liver disease in mice.
    Yu Y; Tian T; Tan S; Wu P; Guo Y; Li M; Huang M
    Bioengineered; 2022 Feb; 13(2):2927-2942. PubMed ID: 35038955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
    Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
    Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA Gm28382 promotes lipogenesis by interacting with miR-326-3p to regulate ChREBP signaling pathway in NAFLD.
    Yang S; Zhang Y; Zhang Y; Yin L; Han X; Zhao X; Wang N; Xu L
    Int Immunopharmacol; 2024 Jan; 127():111444. PubMed ID: 38157698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-103a-3p promotes inflammation and fibrosis in nonalcoholic fatty liver disease by targeting HBP1.
    Chu K; Gu J
    Immunopharmacol Immunotoxicol; 2022 Dec; 44(6):993-1003. PubMed ID: 35848933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
    Zhuge B; Li G
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.